Hypertension, renin-angiotensin-aldosterone system inhibition, and COVID-19

Affiliations

¹ Institute of Cardiovascular Sciences, University College London, and National Institute for Health Research University College London Biomedical Research Centre, London, W1T 7DN, UK. Electronic address: bryan.williams@ucl.ac.uk.
² Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.

Comment

Bryan Williams et al. Lancet. 2020.

. 2020 May 30;395(10238):1671-1673.

doi: 10.1016/S0140-6736(20)31131-4. Epub 2020 May 14.

¹ Institute of Cardiovascular Sciences, University College London, and National Institute for Health Research University College London Biomedical Research Centre, London, W1T 7DN, UK. Electronic address: bryan.williams@ucl.ac.uk.
² Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.

No abstract available

Figures

Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study.
de Abajo FJ, Rodríguez-Martín S, Lerma V, Mejía-Abril G, Aguilar M, García-Luque A, Laredo L, Laosa O, Centeno-Soto GA, Ángeles Gálvez M, Puerro M, González-Rojano E, Pedraza L, de Pablo I, Abad-Santos F, Rodríguez-Mañas L, Gil M, Tobías A, Rodríguez-Miguel A, Rodríguez-Puyol D; MED-ACE2-COVID19 study group. de Abajo FJ, et al. Lancet. 2020 May 30;395(10238):1705-1714. doi: 10.1016/S0140-6736(20)31030-8. Epub 2020 May 14. Lancet. 2020. PMID: 32416785 Free PMC article.

1. Huang C, Wang Y, Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. - PMC - PubMed
1. Chen Y, Guo Y, Pan Y, Zhao ZJ. Structure analysis of the receptor binding of 2019-nCoV. Biochem Biophys Res Commun. 2020 doi: 10.1016/j.bbrc.2020.02.071. published online Feb 17. - DOI - PMC - PubMed
1. Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8:e21. - PMC - PubMed
1. de Abajo FJ, Rodríguez-Martín S, Lerma V. Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study. Lancet. 2020 doi: 10.1016/S0140-6736(20)31030-8. published online May 14. - DOI - PMC - PubMed
1. Li J, Wang X, Chen J, Zhang H, Deng A. Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China. JAMA Cardiol. 2020 doi: 10.1001/jamacardio.2020.1624. published online April 23. - DOI - PMC - PubMed